Near infrared light activation of an injectable whole-cell cancer vaccine for cancer immunoprophylaxis and immunotherapy

Author:

Wang Fei12345,Gao Junbin12345,Wang Shuanghu12345,Jiang Jiamiao12345,Ye Yicheng12345,Ou Juanfeng12345,Liu Shuwen12345ORCID,Peng Fei6785ORCID,Tu Yingfeng12345ORCID

Affiliation:

1. School of Pharmaceutical Sciences

2. Guangdong Provincial Key Laboratory of New Drug Screening

3. Southern Medical University

4. Guangzhou 510515

5. China

6. School of Materials Science and Engineering

7. Sun Yat-Sen University

8. Guangzhou 510275

Abstract

An injectable live-cell cancer vaccine (InLCCV) has been successfully constructed. Upon near-infrared (NIR) laser irradiation, InLCCV can activate the body's immune response and can be used for cancer immunoprophylaxis and immunotherapy.

Funder

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Reference35 articles.

1. Global cancer statistics

2. International Agency for Research on Cancer (IARC) , Latest global cancer data: cancer burden rises to 19.3 million new cases and 10.0 million cancer deaths in 2020, https://www.iarc.fr/faq/latest-global-cancer-data-2020-qa/

3. Breast Cancer Vaccines: New Insights

4. Cancer Immunotherapy: A Treatment for the Masses

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3